According to the present allele frequency distribution data of all cancer patients, only 27 patients of 203 (13%) had the TNF-α 308G/A (rs1800629) mutation, whereas approximately seven times more patients carried the wild-type allele (176 patients, i.e., 87% of the total number). This evidence concerns the gene TNF and cancer.